Previous studies have shown that ABCG2 and human clusters of differentiation 33 (CD133) markers are highly expressed in drug-resistant and highly tumorigenic cell lines, such as MDA-MB-231 and MCF-7, which resemble cancer stem cells (CSCs) [32]. This evidence concerns the gene ABCG2 and cancer.